These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term outcome after sclerotherapy with or without a beta-blocker for variceal bleeding in children. Sökücü S, Süoglu OD, Elkabes B, Saner G. Pediatr Int; 2003 Aug; 45(4):388-94. PubMed ID: 12911472 [Abstract] [Full Text] [Related]
3. Propranolol or endoscopic sclerotherapy in the prevention of recurrence of variceal bleeding. A prospective, randomized controlled trial. Alexandrino PT, Alves MM, Pinto Correia J. J Hepatol; 1988 Oct; 7(2):175-85. PubMed ID: 3057063 [Abstract] [Full Text] [Related]
4. Does propranolol maintain post-sclerotherapy variceal obliteration? A prospective randomized study. Lo GH, Lai KH, Lee SD, Tsai YT, Lo KJ. J Gastroenterol Hepatol; 1993 Oct; 8(4):358-62. PubMed ID: 8374092 [Abstract] [Full Text] [Related]
5. Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions. Lundell L, Leth R, Lind T, Lönroth H, Sjövall M, Olbe L. Acta Chir Scand; 1990 Oct; 156(10):711-5. PubMed ID: 2264429 [Abstract] [Full Text] [Related]
7. A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding. Westaby D, Polson RJ, Gimson AE, Hayes PC, Hayllar K, Williams R. Hepatology; 1990 Mar; 11(3):353-9. PubMed ID: 2179096 [Abstract] [Full Text] [Related]
8. Management of portal hypertension in children: a retrospective study with long-term follow-up. Erkan T, Cullu F, Kutlu T, Emir H, Yeşildağ E, Sarimurat N, Senyüz OF, Erginöz E, Tümay GT. Acta Gastroenterol Belg; 2003 Mar; 66(3):213-7. PubMed ID: 14618951 [Abstract] [Full Text] [Related]
10. [Sclerotherapy of esophageal varices using ethanol in combination with propranolol: clinical study of 30 patients]. Poynard T, Aubert A, Naveau S, Lemman M, Chaput JC. Gastroenterol Clin Biol; 1988 Dec; 12(12):899-905. PubMed ID: 3069544 [Abstract] [Full Text] [Related]
11. Propranolol may prevent recurrence of oesophageal varices after obliteration by endoscopic sclerotherapy. Jensen LS, Krarup N. Scand J Gastroenterol; 1990 Apr; 25(4):352-6. PubMed ID: 2336545 [Abstract] [Full Text] [Related]
19. Comparison of propranolol with injection sclerotherapy in prevention of rebleeding from oesophageal varices in cirrhotic patients. Westaby D, Polson R, Gimson A, Hayes P, Williams R. Drugs; 1989 May; 37 Suppl 2():42-6; discussion 47. PubMed ID: 2806133 [Abstract] [Full Text] [Related]
20. [Endoscopic sclerotherapy versus propranolol after hemorrhage caused by rupture of esophageal varices in patients with cirrhosis. Results of a 4-year randomized study]. Dollet JM, Champigneulle B, Patris A, Bigard MA, Gaucher P. Gastroenterol Clin Biol; 1988 Mar; 12(3):234-9. PubMed ID: 3259521 [Abstract] [Full Text] [Related] Page: [Next] [New Search]